Jim Simons Neogenomics Inc Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Neogenomics Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 15,300 shares of NEO stock, worth $247,248. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,300

Previous 141,600 89.19%

Holding current value

$247,248

Previous $2.23 Million 90.48%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$13.01 - $15.77 $1.64 Million - $1.99 Million	-126,300 Reduced 89.19%	15,300 $212,000
Q1 2024 May 13, 2024	BUY	$14.06 - $16.79 $587,708 - $701,822	41,800 Added 41.88%	141,600 $2.23 Million
Q4 2023 Feb 13, 2024	SELL	$11.67 - $20.73 $1.44 Million - $2.56 Million	-123,300 Reduced 55.27%	99,800 $1.62 Million
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $2.71 Million - $3.98 Million	223,100 New	223,100 $2.74 Million
Q2 2022 Aug 12, 2022	SELL	$7.06 - $13.97 $1.74 Million - $3.44 Million	-246,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$12.15 - $35.28 $2.99 Million - $8.68 Million	246,000 New	246,000 $2.99 Million
Q4 2019 Feb 13, 2020	SELL	$18.96 - $29.84 $2.27 Million - $3.57 Million	-119,500 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$19.12 - $26.24 $2.28 Million - $3.14 Million	119,500 New	119,500 $2.29 Million
Q1 2019 May 14, 2019	SELL	$12.14 - $20.46 $4.89 Million - $8.24 Million	-402,700 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$11.24 - $18.5 $4.53 Million - $7.45 Million	402,700 New	402,700 $5.08 Million

Others Institutions Holding NEO

# of Institutions

278

Shares Held

127M

Call Options Held

581K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.03B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account